Lilly expects orforglipron obesity results in third quarter
June 21 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the drug in overweight and obese people without diabetes.
Lilly expects to submit the non-diabetes Phase 3 data to global regulatory agencies by the end of the year, said Ken Custer, head of cardiometabolic health at the company. The U.S. Food and Drug Administration typically makes new drug approval decisions 10 months after a manufacturer's submission.
Lilly said it plans to file for regulatory approvals for orforglipron as a diabetes treatment in 2026.
Full results of the diabetes trial were presented at the annual meeting of the American Diabetes Association in Chicago.
The Phase 3 study showed that type 2 diabetes patients taking the highest dose of daily orforglipron lost nearly 8% of their body weight over 40 weeks. That compares favorably with Novo Nordisk's (NOVOb.CO), opens new tab injected drug Ozempic, for which trials showed that diabetic patients on the highest dose lost roughly 6% of their body weight.
Lilly's pill, which can be taken without food or water, lowered blood sugar levels by an average of 1.3% to 1.6% across doses.
The company said the most frequently reported side effects were gastrointestinal and similar to other GLP-1 drugs, including diarrhea and vomiting.
Custer said Lilly's goal in its non-diabetes trials is to achieve weight loss consistent with GLP-1 drugs that are currently available. Ozempic was shown in trials to lead to weight loss of 15% for people without diabetes over 68 weeks.
He said orforglipron, which has a simpler production process than injected GLP-1 drugs such as Ozempic or Lilly's Zepbound and does not require cold storage, could mean wider global access to weight-loss drugs.
"This is the type of molecule that is going to allow us to reach the broader globe," Custer said.
The executive declined to comment on pricing plans for orforglipron.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
Deadly waterborne bacteria reaches dangerous levels at two popular family beaches
Those looking to swim in two popular beaches on Lake Erie this weekend have been warned of high E. coli levels infecting the waters. Edgewater and Villa Angela Beach, located on the edge of Cleveland, Ohio, have been issued a water quality advisory due to high levels of waterborne bacteria, according to the Northeast Ohio Regional Sewer District. Edgewater Beach had an E. coli reading of 90 MPN/100 mL, while the water of Villa Angela read a whopping 315 MPN/100 mL. E. coli is measured in a measurement called MPN (most probable number), which estimates the amount of E. coli cells in a liquid sample. The E. coli threshold for Edgewater is set at 80 MPN/100 mL, and Villa Beach is 135 MPN/100 mL. Since both beaches had an E. coli measurement above their threshold, experts have advised against swimming in the water. Both beaches are still open, but patrons are advised that swimming in the water could result in contact with the potentially deadly bacteria. The Northeast Ohio Regional Sewer District collects data on contaminated water using the Nowcast system. The system uses rainfall patterns and wind direction to predict the water quality of the lakes. This weekend's Nowcast system predicted poor water quality, urging children, the elderly, and those with health concerns to stay away from swimming. E. coli infections impact your gut and urinary tract, resulting in symptoms such as diarrhea, vomiting, and a fever. Around 17 percent of those who contract E. coli die from the infection, according to the Cleveland Clinic. Although the percentage isn't high, vulnerable populations are at an enhanced risk. Those with diabetes, weakened immune systems, who are over the age of 65, or are young children are at the greatest risk of infection. If the infection spreads to the urinary tract system, it can cause pelvic pain, a burning sensation during urination, and cloudy, foul-smelling urine. E. coli is mostly spread through fecal-oral transmission when the bacteria are too small to see. Sepsis is the most common cause of death for those infected with E. coli. The condition occurs when the body's immune system can't fight off an infection and can lead to organ failure. The infection is contagious and can spread by touching contaminated objects, surfaces, or food. E. coli typically infects lakes and water sources after a rainstorm when animal feces are washed into the water. Aging sewage pipes can also leak contaminated water into lakes.
The Guardian
5 hours ago
- The Guardian
Key RFK Jr advisers stand to profit from a new federal health initiative
Federal health officials are seeking to launch a 'bold, edgy' public service campaign to warn Americans of the dangers of ultra-processed foods in social media, transit ads, billboards and even text messages. And they potentially stand to profit off the results. Ultra-processed foods are a fixation for the US health and human services (HHS) secretary, Robert F Kennedy Jr, a vaccine skeptic who believes the US industrialized food supply is a 'primary culprit' behind many chronic diseases. 'We need to fix our food supply. And that's the number one thing,' Kennedy said at his confirmation hearing. Bringing healthier foods to Americans has proved to be one of the most resonant issues of Kennedy's 'Make America healthy again' (Maha) campaign – and arguably the only one that Democrats and Republicans agree on in principle. Kennedy has spent most of his tenure as health secretary dismantling key components of US vaccine infrastructure, instituting mass firings and defunding chronic disease prevention programs, such as for tobacco use. The secretary has been less successful in reigning in food makers. Food advocates have described voluntary changes between the government and manufacturers 'disappointing'. Kennedy was criticized by congressional Republicans for targeting agricultural pesticides in the 'Maha' report before it was even released – showing the limits of Republicans appetite for regulation, then the report itself was riddled with errors, likely generated by AI. 'The campaign's creative content will turn heads, create viral moments on social media, and – above all else – inspire Americans to take back their health through eating real food,' said a document published by the federal government that described the campaign. The campaign is expected to cost between $10m to $20m, according to documents. Anyone seeking to apply for the award will have a quick turnaround – the deadline is 26 June. 'The purpose of this requirement is to alert Americans to the role of processed foods in fueling the diabetes epidemic and other chronic diseases, inspire people to take personal responsibility for their diets, and drive measurable improvements in diabetes prevention and national health outcomes,' it continued. The new public relations campaign also highlights the Trump administration's unconventional approach to hiring – including its reliance on special government employees. A key adviser to Kennedy, Calley Means, could directly benefit from one of the campaign's stated aims: popularizing 'technology like wearables as cool, modern tools for measuring diet impact and taking control of your own health'. Calley Means is a senior Kennedy adviser, and was hired as a special government employee to focus on food policy, according to Bloomberg. He founded a company that helps Americans get such wearable devices reimbursed tax-free through health savings accounts. Casey Means is Calley's sister. She also runs a healthcare start-up, although hers sells wearable devices such as continuous glucose monitors. She is Kennedy's nominee for US surgeon general, and a healthcare entrepreneur whose business sells continuous glucose monitors – one such wearable device. Calley Means's company also works with Casey's company. Due to Calley Means's status as a special employee, he has not been forced to divest from his private business interests – a situation that has already resulted in an ethics complaint. Consumer advocates, such as the non-profit group Public Citizen, had warned such hiring practices could cause conflicts of interest. HHS did not respond to a request for comment about Calley Means's private business interests, or his role in crafting the publicity campaign. Although the publicity campaign focuses on the ultra-processed foods connection to diabetes, at least one high profile nutritionist was queasy about its focus. 'The ultra-processed foods – some of those include breakfast cereals that are ultra-processed because they are fortified with vitamins,' said Walter Willett, a professor of epidemiology and nutrition at the Harvard TH Chan School of Public Health. 'Those are good if they're whole grain breakfast cereals and whole grain breads,' he said. Ultra-processed foods are generally recognized as sodas, salty snacks and frozen meals engineered to be shelf-stable, convenient and inexpensive. Such foods are associated with increased risk of type 2 diabetes – or insulin resistance. The mechanism by which such foods could increase risk of diabetes is unknown, a problem that extends in part from the 'heterogeneous category' of foods that the ultra-processed category encompasses. The publicity campaign proposal does not venture into defining the category, even as Kennedy has fixated on it 'poisoning the American people'. 'When you say processed foods you don't envision a Coke in your brain, and that's the biggest problem,' said Willett, who added that most public service campaigns are carefully crafted and tested for effectiveness.
Evening Standard
6 hours ago
- Evening Standard
The new Ozempic? Weight-loss pill Amycretin could be more effective than jabs
Novo Nordisk, the Danish pharmaceutical company behind amycretin — and also the maker of Wegovy and Ozempic — hopes the pill version of amycretin could make weight-loss therapy more accessible, especially in Britain, where around 1.5 million people currently receive weight-loss treatments, mostly as injections prescribed through specialised clinics or by private providers.
